Delivery Order SPE2DB25D3017-SPE2DB25FVJNC
Award Date 6/20/25
Potential Completion Date 6/23/25
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $35,031.63 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ENBREL is a biologic immunosuppressant medication used to treat autoimmune conditions...
- The Defense Logistics Agency awarded a $25,638.42 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors, with an ultimate completion date of June 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ENBREL is a biologic immunosuppressant medication used to treat rheumatoid arthritis and other inflammatory conditions,...
- The Defense Logistics Agency awarded a delivery order valued at $49,259.33 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. ENBREL (etanercept) is a biologic immunosuppressant commonly used to treat rheumatoid arthritis,...
- The Defense Logistics Agency awarded a $40,735.58 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of September 3, 2025. This non-set-aside award was issued on September 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ENBREL is a biologic immunosuppressant medication commonly used to treat rheumatoid arthritis and other autoimmune conditions,...
- The Defense Logistics Agency awarded a delivery order valued at $10,388.67 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injector pens. This competitive, firm fixed-price delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Enbrel is a biologic immunosuppressant medication used to treat rheumatoid arthritis and other autoimmune...
- The Defense Logistics Agency awarded a $21,306.27 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract was not set aside for small business or other designated groups and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. ENBREL (etanercept) is a biologic immunosuppressant medication commonly used to...
- The Defense Logistics Agency awarded a delivery order valued at $91,716.73 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of September 29, 2025. This is a firm fixed-price, non-set-aside delivery order issued on September 27, 2025, with performance to take place at AmerisourceBergen's Conshohocken, Pennsylvania headquarters. ENBREL is a biologic immunosuppressant medication used to treat rheumatoid arthritis, psoriasis, and other...
- The Defense Logistics Agency awarded a $25,703.25 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injector pens, with an ultimate completion date of October 28, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ENBREL (etanercept) is a biologic immunosuppressant used to treat rheumatoid arthritis, psoriasis,...
- The Defense Logistics Agency awarded a $23,790.42 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick autoinjectors, with an ultimate completion date of August 5, 2025. This non-set-aside award was issued on August 4, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. ENBREL (etanercept) is a biologic immunosuppressant used to treat rheumatoid arthritis, psoriasis, and other inflammatory conditions,...
- The Defense Logistics Agency awarded a delivery order valued at $11,160.01 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. ENBREL is a biologic immunosuppressant commonly used to treat rheumatoid arthritis, psoriasis, and other autoimmune...